Synthetic Control Arm® in Clinical Trials

By Medidata

A Synthetic Control Arm® is a type of external control that is generated using external patient-level data to improve the interpretation of uncontrolled trials. They can help enhance the scientific validity of single-arm trials; in certain indications, and can reduce time and costs associated with trials, and expose fewer patients to placebos or existing standard-of-care treatments that might not be effective for them. See how a Synthetic Control Arm® can benefit your trials, including: - Defining a Synthetic Control Arm® - Components needed to build a Synthetic Control Arm® - Benefits for patients and sponsors - Case studies in non-small-cell lung cancer (NSCLC), multiple myeloma, and from Celsion Corporation

Enter your details to receive the free white paper:

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.